Elena Birman

2.2k total citations
33 papers, 1.7k citations indexed

About

Elena Birman is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Elena Birman has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Oncology. Recurrent topics in Elena Birman's work include Mesenchymal stem cell research (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Elena Birman is often cited by papers focused on Mesenchymal stem cell research (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Elena Birman collaborates with scholars based in Canada, United States and Denmark. Elena Birman's co-authors include Jacques Galipeau, Kathy Forner, Moutih Rafei, Marie‐Noëlle Boivin, Michaël Pollak, Shala Yuan, Yoon Kow Young, Carolyn Algire, Philippe M. Campeau and Gerardo Ferbeyre and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Elena Birman

33 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Birman Canada 20 809 645 378 325 324 33 1.7k
Peetra U. Magnusson Sweden 24 963 1.2× 418 0.6× 457 1.2× 359 1.1× 605 1.9× 51 2.3k
Cécile Duplàa France 27 1.3k 1.7× 434 0.7× 287 0.8× 202 0.6× 522 1.6× 54 2.3k
Nathalie Gallay France 18 825 1.0× 741 1.1× 221 0.6× 313 1.0× 348 1.1× 33 1.8k
Rebecca Pelekanos Australia 14 761 0.9× 809 1.3× 191 0.5× 335 1.0× 599 1.8× 19 1.8k
Nathalie Baeza France 17 1.2k 1.4× 887 1.4× 134 0.4× 431 1.3× 372 1.1× 28 2.2k
Osamu Tachibana Japan 23 1.2k 1.4× 1.1k 1.7× 240 0.6× 571 1.8× 368 1.1× 105 2.7k
Jamie Case United States 21 1.3k 1.6× 430 0.7× 251 0.7× 373 1.1× 439 1.4× 63 2.2k
Angelina Felici Italy 21 1.3k 1.6× 272 0.4× 225 0.6× 486 1.5× 204 0.6× 39 2.4k
Giuseppe Mangialardi Italy 19 742 0.9× 318 0.5× 204 0.5× 468 1.4× 248 0.8× 32 1.6k

Countries citing papers authored by Elena Birman

Since Specialization
Citations

This map shows the geographic impact of Elena Birman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Birman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Birman more than expected).

Fields of papers citing papers by Elena Birman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Birman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Birman. The network helps show where Elena Birman may publish in the future.

Co-authorship network of co-authors of Elena Birman

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Birman. A scholar is included among the top collaborators of Elena Birman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Birman. Elena Birman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blouin, Marie‐José, Miguel Bazile, Elena Birman, et al.. (2015). Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia. Breast Cancer Research and Treatment. 149(3). 577–585. 15 indexed citations
2.
Gravel, Simon‐Pierre, Laura Hulea, Elena Birman, et al.. (2014). Serine Deprivation Enhances Antineoplastic Activity of Biguanides. Cancer Research. 74(24). 7521–7533. 105 indexed citations
3.
Hvid, Henning, Elena Birman, Jesper Damgaard, et al.. (2013). Treatment with Insulin Analog X10 and IGF-1 Increases Growth of Colon Cancer Allografts. PLoS ONE. 8(11). e79710–e79710. 31 indexed citations
4.
Algire, Carolyn, Olga Moiseeva, Xavier Deschênes‐Simard, et al.. (2012). Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. Cancer Prevention Research. 5(4). 536–543. 288 indexed citations
5.
6.
Rafei, Moutih, Elena Birman, Jessica Cuerquis, et al.. (2012). Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization. Molecular Therapy. 20(9). 1767–1777. 7 indexed citations
8.
Hvid, Henning, Sarah‐Maria Fendt, Marie‐José Blouin, et al.. (2012). Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway. Endocrine Related Cancer. 19(4). 557–574. 9 indexed citations
9.
Blouin, Marie‐José, Mahvash Zakikhani, Stéphanie David, et al.. (2011). Metformin abolishes increased tumor18F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet. Cell Cycle. 10(16). 2770–2778. 32 indexed citations
10.
Rafei, Moutih, Jiusheng Deng, Marie‐Noëlle Boivin, et al.. (2011). A MCP1 fusokine with CCR2-specific tumoricidal activity. Molecular Cancer. 10(1). 121–121. 17 indexed citations
11.
Eliopoulos, Nicoletta, Jing Zhao, Kathy Forner, et al.. (2011). Erythropoietin Gene-enhanced Marrow Mesenchymal Stromal Cells Decrease Cisplatin-induced Kidney Injury and Improve Survival of Allogeneic Mice. Molecular Therapy. 19(11). 2072–2083. 31 indexed citations
13.
Rafei, Moutih, Manaf Bouchentouf, Jennifer F. Raven, et al.. (2010). A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo. Molecular Therapy. 18(7). 1293–1301. 25 indexed citations
14.
Rafei, Moutih, Philippe M. Campeau, Jian Wu, et al.. (2009). Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine. The Journal of Immunology. 182(5). 2620–2627. 14 indexed citations
15.
Rafei, Moutih, Philippe M. Campeau, Adriana Aguilar‐Mahecha, et al.. (2009). Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner. The Journal of Immunology. 182(10). 5994–6002. 296 indexed citations
16.
Birman, Elena, et al.. (2009). Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo. Cancer Chemotherapy and Pharmacology. 65(6). 1047–1056. 32 indexed citations
17.
Rafei, Moutih, Elena Birman, Kathy Forner, & Jacques Galipeau. (2009). Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis. Molecular Therapy. 17(10). 1799–1803. 110 indexed citations
18.
Campeau, Philippe M., et al.. (2008). Mesenchymal Stromal Cells Engineered to Express Erythropoietin Induce Anti-erythropoietin Antibodies and Anemia in Allorecipients. Molecular Therapy. 17(2). 369–372. 30 indexed citations
19.
Rafei, Moutih, Simon Fortier, Mengyang Li, et al.. (2008). Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood. 112(13). 4991–4998. 183 indexed citations
20.
Shi, Zhihua, Elena Birman, & H. Uri Saragovi. (2007). Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cellsin vivo. Developmental Neurobiology. 67(7). 884–894. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026